The investigation of adrenergic metabolism with 7H3-norepinephrine in psychiatric disorders. II. Temporal changes in the distribution of urinary tritiated metabolites in affective disorders.
D000275:Adjustment Disorders / Q000378:metabolism*; D000328:Adult; D000368:Aged; D000588:Amines / Q000652:urine*; D001714:Bipolar Disorder / Q000378:metabolism*; D003863:Depression / Q000378:metabolism*; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008333:Mandelic Acids / Q000652:urine; D008875:Middle Aged; D008996:Monoamine Oxidase Inhibitors; D009638:Norepinephrine / Q000378:metabolism* / Q000652:urine; D009647:Normetanephrine / Q000652:urine; D010084:Oxidation-Reduction; D009435:Synaptic Transmission; D013997:Time Factors; D014316:Tritium; D014642:Vanilmandelic Acid / Q000652:urine
D000588:Amines; D008333:Mandelic Acids; D008996:Monoamine Oxidase Inhibitors; D009647:Normetanephrine; D014316:Tritium; D014642:Vanilmandelic Acid; D009638:Norepinephrine